Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Hussain, Azhar R ^a   Uddin, Shahab ^a   Bu, Rong ^a   Khan, Omar S ^a   Ahmed, Saeeda O ^a   Ahmed, Maqbool ^a   Al Kuraya, Khawla S ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 5; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RESVERATROL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; CYTOCHROME C; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; GENE SILENCING; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; PROTEIN SECRETION; UPREGULATION; CELL SURVIVAL; DRUG EFFECT; IMMUNOBLOTTING; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROMES C; HUMANS; IMMUNOBLOTTING; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES;

EID: 80052623226     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024703     Document Type: Article

References (47)

1. American Society of Hematology (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89: 3909-3918.
2. Escalon MP, Lossos IS, (2008) Pharmacotherapy of large B-cell lymphoma. Expert Opin Pharmacother 9: 2247-2258.
3. Fisher RI, (1997) Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphoma. Cancer Chemother Pharmacol 40 (Suppl): S42-46.
4. Hussain AR, Khan AS, Ahmed SO, Ahmed M, Platanias LC, et al. (2010) Apigenin induces apoptosis via downregulation of S-phase kinase-associated protein 2-mediated induction of p27Kip1 in primary effusion lymphoma cells. Cell Prolif 43: 170-183.
5. Uddin S, Hussain AR, Ahmed M, Abubaker J, Al-Sanea N, et al. (2009) High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target. Am J Gastroenterol 104: 1790-1801.
6. Uddin S, Hussain AR, Siraj AK, Manogaran PS, Al-Jomah NA, et al. (2006) Role of phosphatidylinositol 3′-kinase/AKT pathway in diffuse large B-cell lymphoma survival. Blood 108: 4178-4186.
7. Uddin S, Siraj AK, Al-Rasheed M, Ahmed M, Bu R, et al. (2008) Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers. J Clin Endocrinol Metab 93: 4088-4097.
8. Terragni J, Graham JR, Adams KW, Schaffer ME, Tullai JW, et al. (2008) Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors. BMC Cell Biol 9: 6.
9. Trachootham D, Lu W, Ogasawara MA, Nilsa RD, Huang P, (2008) Redox regulation of cell survival. Antioxid Redox Signal 10: 1343-1374.
10. Stowe DF, Camara AK, (2009) Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal 11: 1373-1414.
11. Hsieh TC, Wu JM, (2010) Resveratrol: Biological and pharmaceutical properties as anticancer molecule. Biofactors 36: 360-369.
12. Vanamala J, Reddivari L, Radhakrishnan S, Tarver C, (2010) Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer 10: 238.
13. Banerjee Mustafi S, Chakraborty PK, Raha S, (2010) Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70. PLoS One 5: e8719.
14. Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, et al. (2010) Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci 101: 488-493.
15. Galati GSO, Wilson JX, O'Brien PJ, (2002) Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics. Toxicology 177: 91-104.
16. Chandra J, (2009) Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies. Antioxid Redox Signal 11: 1123-1137.
17. Schilder YD, Heiss EH, Schachner D, Ziegler J, Reznicek G, et al. (2009) NADPH oxidases 1 and 4 mediate cellular senescence induced by resveratrol in human endothelial cells. Free Radic Biol Med 46: 1598-1606.
18. Low IC, Chen ZX, Pervaiz S, (2010) Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid Redox Signal 13: 807-819.
19. Roccaro AM, Leleu X, Sacco A, Moreau AS, Hatjiharissi E, et al. (2008) Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenstrom's macroglobulinemia. Clin Cancer Res 14: 1849-1858.
20. Fisher RI, Shah P, (2003) Current trends in large cell lymphoma. Leukemia 17: 1948-1960.
21. Hussain AR, Al-Jomah NA, Siraj AK, Manogaran P, Al-Hussein K, et al. (2007) Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res 67: 3888-3897.
22. Hussain AR, Ahmed M, Al-Jomah NA, Khan AS, Manogaran P, et al. (2008) Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines. Mol Cancer Ther 7: 3318-3329.
23. Uddin S, Hussain AR, Al-Hussein KA, Manogaran PS, Wickrema A, et al. (2005) Inhibition of phosphatidylinositol 3′-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Clin Cancer Res 11: 3102-3108.
24. Uddin S, Hussain AR, Ahmed M, Al-Dayel F, Bu R, et al. (2010) Inhibition of c-MET is a potential therapeutic strategy for treatment of diffuse large B-cell lymphoma. Lab Invest 90: 1346-1356.
25. Hussain AR, Uddin S, Ahmed M, Bu R, Ahmed SO, et al. (2010) Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling. J Pathol 222: 180-190.
26. Le Corre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ, (2005) Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol Nutr Food Res 49: 462-471.
27. Schultz J, (2004) Resveratrol may be a powerful cancer-fighting ally. J Natl Cancer Inst 96: 1497-1498.
28. Hudson TS, Hartle DK, Hursting SD, Nunez NP, Wang TT, et al. (2007) Inhibition of prostate cancer growth by muscadine grape skin extract and resveratrol through distinct mechanisms. Cancer Res 67: 8396-8405.
29. Li Y, Liu J, Liu X, Xing K, Wang Y, et al. (2006) Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated Akt and caspase-9. Appl Biochem Biotechnol 135: 181-192.
30. Fu Z, Tindall DJ, (2008) FOXOs, cancer and regulation of apoptosis. Oncogene 27: 2312-2319.
31. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, et al. (2008) Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res 68: 6643-6651.
32. Inoue A, Muranaka S, Fujita H, Kanno T, Tamai H, et al. (2004) Molecular mechanism of diclofenac-induced apoptosis of promyelocytic leukemia: dependency on reactive oxygen species, Akt, Bid, cytochrome and caspase pathway. Free Radic Biol Med 37: 1290-1299.
33. Paraiso KH, Xiang Y, Rebecca VW, Abel EV, Chen YA, et al. (2011) PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression. Cancer Res 71: 2750-2760.
34. Liu KW, Feng H, Bachoo R, Kazlauskas A, Smith EM, et al. (2011) SHP-2/PTPN11 mediates gliomagenesis driven by PDGFRA and INK4A/ARF aberrations in mice and humans. J Clin Invest 121: 905-917.
35. Cuevas B, Lu Y, Watt S, Kumar R, Zhang J, et al. (1999) SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J Biol Chem 274: 27583-27589.
36. Samovski D, Kalderon B, Yehuda-Shnaidman E, Bar-Tana J, (2010) Gating of the mitochondrial permeability transition pore by long chain fatty acyl analogs in vivo. J Biol Chem 285: 6879-6890.
37. Clodi K, Wimmer D, Li Y, Goodwin R, Jaeger U, et al. (2000) Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells. Br J Haematol 111: 580-586.
38. Ashkenazi A, Dixit VM, (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11: 255-260.
39. Hussain AR, Ahmed M, Ahmed S, Manogaran P, Platanias LC, et al. (2011) Thymoquinone suppresses growth and induces apoptosis via generation of reactive oxygen species in primary effusion lymphoma. Free Radic Biol Med 50: 978-987.
40. Bremer E, van Dam G, Kroesen BJ, de Leij L, Helfrich W, (2006) Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol Med 12: 382-393.
41. Hussain AR, Al-Rasheed M, Manogaran PS, Al-Hussein KA, Platanias LC, et al. (2006) Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11: 245-254.
42. Lee TJ, Um HJ, Min do S, Park JW, Choi KS, et al. (2009) Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radic Biol Med 46: 1639-1649.
43. Kwon D, Choi K, Choi C, Benveniste EN, (2008) Hydrogen peroxide enhances TRAIL-induced cell death through up-regulation of DR5 in human astrocytic cells. Biochem Biophys Res Commun 372: 870-874.
44. Prasad S, Yadav VR, Ravindran J, Aggarwal BB, (2011) ROS and CHOP Are Critical for Dibenzylideneacetone to Sensitize Tumor Cells to TRAIL through Induction of Death Receptors and Downregulation of Cell Survival Proteins. Cancer Res 71: 538-549.
45. Prasad S, Yadav VR, Kannappan R, Aggarwal BB, (2010) Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-Independent upregulation of death receptors: Evidence for the role of reactive oxygen species and C-Jun N-terminal kinase. J Biol Chem 286 doi:10.1074/jbc.M110.183699.
46. Pervaiz S, Holme AL, (2009) Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal 11: 2851-2897.
47. Horndasch M, Culig Z, (2011) SOCS-3 antagonizes pro-apoptotic effects of TRAIL and resveratrol in prostate cancer cells. Prostate doi:10.1002/pros.21353.